메뉴 건너뛰기




Volumn 27, Issue 9, 2002, Pages 448-455

Short-term cost-effectiveness of bisphosphonate therapies for postmenopausal osteoporotic women at high risk of fracture

Author keywords

Cost; Cost effectiveness; Osteoporosis; Postmenopausal women; Quality adjusted life years

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID;

EID: 0036733574     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (22)

References (38)
  • 3
    • 0030704306 scopus 로고    scopus 로고
    • Prevalence of low femoral bone density in older US adults from NHANES III
    • Looker AC, Orwoll EX, Johnston CC Jr, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997;12:1761-1768.
    • (1997) J Bone Miner Res , vol.12 , pp. 1761-1768
    • Looker, A.C.1    Orwoll, E.X.2    Johnston C.C., Jr.3
  • 4
    • 0002349672 scopus 로고    scopus 로고
    • Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effective analysis
    • National Osteoporosis Foundation. Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effective analysis. Osteoporos Int 1998(suppl 4);S1-S88.
    • (1998) Osteoporos Int , Issue.SUPPL. 4
  • 5
    • 0029850615 scopus 로고    scopus 로고
    • Prevention and management of osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada
    • Hanley DA, Josse RG. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. Can Med Assoc J 1996;155(7):921-948.
    • (1996) Can Med Assoc J , vol.155 , Issue.7 , pp. 921-948
    • Hanley, D.A.1    Josse, R.G.2
  • 6
    • 0035253489 scopus 로고    scopus 로고
    • Effect of risedronate on the risk of hip fracture in elderly women
    • McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344(5):333-340.
    • (2001) N Engl J Med , vol.344 , Issue.5 , pp. 333-340
    • McClung, M.R.1    Geusens, P.2    Miller, P.D.3
  • 7
    • 0030840642 scopus 로고    scopus 로고
    • Modelling in economic evaluation: An unavoidable fact of life
    • Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: An unavoidable fact of life. Health Econ 1997;6:217-222.
    • (1997) Health Econ , vol.6 , pp. 217-222
    • Buxton, M.J.1    Drummond, M.F.2    Van Hout, B.A.3
  • 9
    • 0027204989 scopus 로고
    • Prevalence and incidence of vertebral deformities
    • Melton LJ III, Lane AW, Cooper C, et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3:113-119.
    • (1993) Osteoporos Int , vol.3 , pp. 113-119
    • Melton L.J. III1    Lane, A.W.2    Cooper, C.3
  • 10
    • 0035178263 scopus 로고    scopus 로고
    • Challenges for model-based economic evaluations of postmenopansal osteoporosis interventions
    • Tosteson ANA, Jönsson B, Grima DT, et al. Challenges for model-based economic evaluations of postmenopansal osteoporosis interventions. Osteoporos Int 2001;12(10):849-857.
    • (2001) Osteoporos Int , vol.12 , Issue.10 , pp. 849-857
    • Tosteson, A.N.A.1    Jönsson, B.2    Grima, D.T.3
  • 11
    • 84992849681 scopus 로고
    • Effectiveness and costs of osteoporosis screening and hormone replacement therapy
    • Washington DC: U.S. Government Printing Office
    • U.S. Office of Technology Assessment. Effectiveness and costs of osteoporosis screening and hormone replacement therapy. Vol II: Evidence on benefits, risks and costs. Washington DC: U.S. Government Printing Office, 1995.
    • (1995) Evidence on benefits, risks and costs , vol.2
  • 12
    • 0025153446 scopus 로고
    • Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy
    • Tosteson AN, Rosenthal DI, Melton LJ III, et al. Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy. Ann Intern Med 1990;113(8):594-603.
    • (1990) Ann Intern Med , vol.113 , Issue.8 , pp. 594-603
    • Tosteson, A.N.1    Rosenthal, D.I.2    Melton L.J. III3
  • 14
    • 0027772390 scopus 로고
    • Markov models in medical decision making: A practical guide
    • Sonnenberg F, Beck J. Markov models in medical decision making: A practical guide. Med Decis Making 1993;13:332-338.
    • (1993) Med Decis Making , vol.13 , pp. 332-338
    • Sonnenberg, F.1    Beck, J.2
  • 16
    • 0034069134 scopus 로고    scopus 로고
    • Risk of hip fracture derived from relative risks: An analysis applied to the population of Sweden
    • Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 2000;11(2):120-127.
    • (2000) Osteoporos Int , vol.11 , Issue.2 , pp. 120-127
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3
  • 17
    • 0028262189 scopus 로고
    • Risk of hip fracture in women with vertebral fracture
    • Kotowicz MA, Melton LJ III, Cooper C, et al. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 1994;9(5):599-605.
    • (1994) J Bone Miner Res , vol.9 , Issue.5 , pp. 599-605
    • Kotowicz, M.A.1    Melton L.J. III2    Cooper, C.3
  • 19
    • 0031765564 scopus 로고    scopus 로고
    • Updated data on proximal femur bone mineral levels of US adults
    • Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8(5):468-489.
    • (1998) Osteoporos Int , vol.8 , Issue.5 , pp. 468-489
    • Looker, A.C.1    Wahner, H.W.2    Dunn, W.L.3
  • 20
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    • Fracture Intervention Trial Research Group
    • Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348(9041): 1535-1541.
    • (1996) Lancet , vol.348 , Issue.9041 , pp. 1535-1541
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3
  • 21
    • 0027422191 scopus 로고
    • Mortality and morbidity after hip fractures
    • Keene SK, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ 1993;307:1248-1250.
    • (1993) BMJ , vol.307 , pp. 1248-1250
    • Keene, S.K.1    Parker, M.J.2    Pryor, G.A.3
  • 22
    • 0031036671 scopus 로고    scopus 로고
    • Medical expenditures for the treatment ofosteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
    • Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment ofosteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12(1):24-35.
    • (1997) J Bone Miner Res , vol.12 , Issue.1 , pp. 24-35
    • Ray, N.F.1    Chan, J.K.2    Thamer, M.3
  • 24
    • 0027510403 scopus 로고
    • The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
    • Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors. Med Decis Making 1993; 13(2):89-102.
    • (1993) Med Decis Making , vol.13 , Issue.2 , pp. 89-102
    • Fryback, D.G.1    Dasbach, E.J.2    Klein, R.3
  • 25
    • 0035698323 scopus 로고    scopus 로고
    • Impact of hip and vertebral fractures on quality-adjusted life years
    • Tosteson ANA, Gabriel SE, Grove MR, et al. Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporos Int 2001;12:1042-1049.
    • (2001) Osteoporos Int , vol.12 , pp. 1042-1049
    • Tosteson, A.N.A.1    Gabriel, S.E.2    Grove, M.R.3
  • 26
    • 0031777481 scopus 로고    scopus 로고
    • Targeting high-risk populations
    • Jönsson B. Targeting high-risk populations. Osteoporos Int 1998(suppl 1);S13-S16.
    • (1998) Osteoporos Int , Issue.SUPPL. 1
    • Jönsson, B.1
  • 27
    • 0027204989 scopus 로고
    • Prevalence and incidence of vertebral deformities
    • Melton LJ III, Lane AW, Cooper C, et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3(3):113-119.
    • (1993) Osteoporos Int , vol.3 , Issue.3 , pp. 113-119
    • Melton L.J. III1    Lane, A.W.2    Cooper, C.3
  • 28
    • 12944291524 scopus 로고    scopus 로고
    • Randomized trial of the effects of risedronate on vertebral fractures in women with established post-menopausal osteoporosis
    • Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
    • Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established post-menopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11(1):83-91.
    • (2000) Osteoporos Int , vol.11 , Issue.1 , pp. 83-91
    • Reginster, J.1    Minne, H.W.2    Sorensen, O.H.3
  • 29
    • 0026611268 scopus 로고
    • Targeted estrogen/progestogen replacement therapy for osteoporosis: Calculation of health care cost savings
    • Clark AP and Schuttinga JA. Targeted estrogen/progestogen replacement therapy for osteoporosis: Calculation of health care cost savings. Osteoporos Int 1992;2:195-200.
    • (1992) Osteoporos Int , vol.2 , pp. 195-200
    • Clark, A.P.1    Schuttinga, J.A.2
  • 30
    • 0010342640 scopus 로고    scopus 로고
    • Hospital costs, days, and post-acute care for vertebral fractures in women
    • Burge RT, Worley DJ. Hospital costs, days, and post-acute care for vertebral fractures in women. Value in Health 2000;3(5):336.
    • (2000) Value in Health , vol.3 , Issue.5 , pp. 336
    • Burge, R.T.1    Worley, D.J.2
  • 31
    • 0028245442 scopus 로고
    • Costs and health effects of osteoporotic fractures
    • Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporotic fractures. Bone 1994;15(4):377-386.
    • (1994) Bone , vol.15 , Issue.4 , pp. 377-386
    • Chrischilles, E.1    Shireman, T.2    Wallace, R.3
  • 32
    • 0023788185 scopus 로고
    • The direct medical costs of osteoporosis for American women aged 45 and older, 1986
    • Phillips S, Fox N, Jacobs J, et al. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 1988;9:271-279.
    • (1988) Bone , vol.9 , pp. 271-279
    • Phillips, S.1    Fox, N.2    Jacobs, J.3
  • 34
    • 0028929689 scopus 로고
    • Cost-effectiveness of fracture prevention in established osteoporosis
    • Jönsson B, Christiansen C, Johnell O, et al. Cost-effectiveness of fracture prevention in established osteoporosis. Osteoporos Int 1995;5:136-142.
    • (1995) Osteoporos Int , vol.5 , pp. 136-142
    • Jönsson, B.1    Christiansen, C.2    Johnell, O.3
  • 35
    • 0000928679 scopus 로고    scopus 로고
    • Alendronate use among 812 women: Prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuation
    • Ettinger B, Pressman A, Schein J, et al. Alendronate use among 812 women: Prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuation. J Manag Care Pharmacy 1998;4(5):488-492.
    • (1998) J Manag Care Pharmacy , vol.4 , Issue.5 , pp. 488-492
    • Ettinger, B.1    Pressman, A.2    Schein, J.3
  • 36
    • 0031733852 scopus 로고    scopus 로고
    • Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis
    • Ettinger B, Pressman A, Schein J. Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis. Am J Manag Care 1998;4(10):1377-1382.
    • (1998) Am J Manag Care , vol.4 , Issue.10 , pp. 1377-1382
    • Ettinger, B.1    Pressman, A.2    Schein, J.3
  • 37
    • 0010343157 scopus 로고    scopus 로고
    • First DataBank, Inc, San Bruno, CA. January 8
    • National Drug Data File. First DataBank, Inc, San Bruno, CA. January 8, 2001.
    • (2001) National Drug Data File


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.